We7–11 and others12,13 have long been focusing on molecular mechanisms to illustrate how ATRA and ATO directly target the stability of PML/RARα to reverse transcriptional deregulation, affecting the proliferation and differentiation of APL cells. This evidence concerns the gene RARA and acute promyelocytic leukemia.